SANCISI, Valentina
 Distribuzione geografica
Continente #
NA - Nord America 1.428
AS - Asia 1.023
EU - Europa 449
SA - Sud America 155
AF - Africa 31
Continente sconosciuto - Info sul continente non disponibili 29
Totale 3.115
Nazione #
US - Stati Uniti d'America 1.352
CN - Cina 339
SG - Singapore 300
VN - Vietnam 131
IT - Italia 123
BR - Brasile 116
GB - Regno Unito 90
HK - Hong Kong 74
KR - Corea 45
RU - Federazione Russa 42
DE - Germania 37
CA - Canada 35
SE - Svezia 30
FR - Francia 27
BD - Bangladesh 24
FI - Finlandia 23
AR - Argentina 20
IN - India 18
MX - Messico 18
ID - Indonesia 17
NL - Olanda 15
TR - Turchia 15
ZA - Sudafrica 15
PL - Polonia 14
UA - Ucraina 14
IQ - Iraq 10
EC - Ecuador 8
JP - Giappone 8
PK - Pakistan 8
AT - Austria 5
CO - Colombia 5
MA - Marocco 5
SA - Arabia Saudita 5
BG - Bulgaria 4
EG - Egitto 4
LT - Lituania 4
SV - El Salvador 4
UZ - Uzbekistan 4
ES - Italia 3
IL - Israele 3
JO - Giordania 3
MY - Malesia 3
PA - Panama 3
PH - Filippine 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BE - Belgio 2
BZ - Belize 2
CH - Svizzera 2
CL - Cile 2
DZ - Algeria 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
IE - Irlanda 2
JM - Giamaica 2
NI - Nicaragua 2
NO - Norvegia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AL - Albania 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GE - Georgia 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
MQ - Martinica 1
MT - Malta 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SN - Senegal 1
SR - Suriname 1
UY - Uruguay 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.087
Città #
Ashburn 202
Singapore 177
Santa Clara 171
Hefei 168
San Jose 123
Council Bluffs 73
Hong Kong 73
Fairfield 55
Los Angeles 48
Ho Chi Minh City 45
Seoul 45
Beijing 42
London 35
Woodbridge 32
Southend 28
Hanoi 27
New York 27
Seattle 27
Boardman 26
Wilmington 26
Houston 24
São Paulo 23
Cambridge 21
The Dalles 21
Chicago 20
Chandler 17
Helsinki 17
Ann Arbor 16
Jacksonville 16
Lauterbourg 16
Bologna 14
Montreal 13
Warsaw 13
Buffalo 12
Kent 12
Modena 12
Da Nang 11
Johannesburg 11
Moscow 11
Nyköping 11
Jakarta 10
Amsterdam 9
Dallas 9
Munich 9
Shanghai 9
Stockholm 9
Denver 8
Mexico City 8
Parma 8
Brooklyn 7
Columbus 7
Orem 7
Poplar 7
Tokyo 7
Chennai 6
Dearborn 6
Nuremberg 6
Princeton 6
Querétaro 6
Atlanta 5
Biên Hòa 5
Frankfurt am Main 5
Milan 5
Phoenix 5
Rome 5
Salt Lake City 5
Baghdad 4
Boston 4
Cairo 4
Cleveland 4
Guangzhou 4
Guayaquil 4
Hải Dương 4
Lahore 4
Miami 4
North Bergen 4
Rio de Janeiro 4
San Salvador 4
Santa Fe 4
Toronto 4
Amman 3
Ankara 3
Athens 3
Austin 3
Belfast 3
Buenos Aires 3
Bắc Ninh 3
Chieti 3
City of London 3
Duncan 3
Eugene 3
Haiphong 3
Karachi 3
Mumbai 3
Ottawa 3
Panama City 3
Quito 3
Redondo Beach 3
San Diego 3
Sofia 3
Totale 2.056
Nome #
Altered Tnnt3 characterizes selective weakness of fast fibers in mice overexpressing FSHD region gene 1 (FRG1) 339
A novel BRAF mutation in association with primary amelanotic melanoma with oral metastases 306
The extent of whole-genome copy number alterations predicts aggressive features in primary melanomas 259
KAP1 is a new non-genetic vulnerability of malignant pleural mesothelioma (MPM) 244
RUNX2 expression in thyroid and breast cancer requires the cooperation of three non-redundant enhancers under the control of BRD4 and c-JUN 180
Patient derived organoids are an useful tool to investigate Hippo pathway involvement in lung cancer 180
The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling 168
Genome-wide profiling identifies the THYT1 signature as a distinctive feature of widely metastatic Papillary Thyroid Carcinomas 162
Harnessing NK Cell Potential Against NSCLC 160
Implementing an organoid platform to assess efficacy of PHD inhibitors as anti-cancer agents 157
Dissecting the role of lncRNAs in promoting Natural Killer cytotoxicity in Non-Small Cell Lung Cancer models 152
PHD2 (EGLN1) is a novel therapeutic target in KRAS-mutated lung carcinoma 151
BET inhibitors drive Natural Killer activation in non-small cell lung cancer via BRD4 and SMAD3 144
LncRNA TAZ-AS202 promotes lung cancer progression through the regulation of the E2F1 transcription factor 142
Unraveling NK Cell-Mediated Cytotoxicity in NSCLC 110
Characterization of EGLN1 as a pro-oncogenic factor and pharmacological target in lung cancer 102
null 83
Exploring EGLN1 as a therapeutic target for KRAS mutated lung cancer 76
Totale 3.115
Categoria #
all - tutte 11.404
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.404


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202236 0 0 0 0 0 4 3 2 10 3 11 3
2022/202363 6 4 5 4 9 9 6 4 5 5 2 4
2023/202480 5 2 9 10 8 6 9 6 2 0 6 17
2024/2025649 6 24 27 39 113 82 61 43 78 39 74 63
2025/20261.634 133 94 155 258 249 112 208 67 156 103 76 23
2026/2027327 44 67 93 123 0 0 0 0 0 0 0 0
Totale 3.115